Near InfraRed Fluorescence Using Indocyanine Green and Magnetic Resonance Lymphography of Lymphatic Transport
Completed · Phase 1
Conditions studied: Rheumatoid Arthritis
In brief
Lymphatic transport will be examined using Near InfraRed Indocyanine Green fluorescence imaging (NIR-ICG) and magnetic resonance lymphography (MRL) of the upper extremities. The purpose of the study is to establish if NIR-ICG is a valid clinical outcome for quantifying lymphatic vessel drainage.
Key facts
- Study ID
- NCT04046146
- Run by
- University of Rochester
- People needed
- 2
- Starts
- 2019-12-15
- Expected to finish
- 2020-03-15
- Last updated by the study team
- 2020-09-04
Who can join
Age: 18 and older, up to 89. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Ability to provide written informed consent.
- Subjects must be 18 years old or older.
You may not qualify if…
- Active systemic disorders or inflammatory conditions (i.e., chronic infections with hepatitis B, hepatitis C or HIV) that would confound the study results.
- Known sensitivity to iodine because of residual iodide in indocyanine green
- Known sensitivity to gadolinium
- Any history of kidney disease
- Pregnant women should not participate; pregnancy tests will not be performed.
Where it is running
- University of Rochester — Rochester, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.